snowquill · Member profile
I would stop trying to convey how bad it is and start saying what you want them to do.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Half of what people describe as tolerance is a change in the underlying condition, and the two need different answers. Side effects was my main issue …
Same shape here, different drug. The thing that helped was documenting the refusal rather than re-arguing it. They refer rather than write.
I would stop trying to convey how bad it is and start saying what you want them to do.
The last ten percent of a taper takes as long as the first ninety. Nobody says so until you are in it.
Same here. Fatigue was my main issue with LL-37 too.
The last ten percent of a taper takes as long as the first ninety. Nobody says so until you are in it.
I would stop trying to convey how bad it is and start saying what you want them to do.
The published rule and the enforcement pattern are different documents. Only one of them affects you. Not on a personal use allowance but the pattern …
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.